secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001558370-24-008450
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Virios Therapeutics prices $1.7M public offering of 8.5M shares at $0.20/share for Long-COVID study prep
--------------------------------------------------------------------------------

- Priced public offering of 8,500,000 shares at $0.20 per share for gross proceeds of approx. $1.7M.
- Net proceeds to fund preparatory activities for planned IMC-2 Long-COVID Phase 2b study and general corporate purposes.
- Offering expected to close on May 22, 2024; Maxim Group LLC acting as sole placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024008450/0001558370-24-008450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024008450/viri-20240519x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer